Form D · Biotechnology
ONL Therapeutics, Inc.
Ann Arbor, MI · CIK 0001611793
Offering snapshot reported Sep 16, 2024 · SEC filing
- Reported sold
- $60M Offering amount: $65M
- Investors reported
- 35 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 12, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 16, 2024 | Initial | $59,999,998 | No comparison | 35 | SEC filing |
| Mar 12, 2024 | Initial | $9,999,948 | No comparison | 35 | SEC filing |
| Mar 15, 2023 | Initial | $4,999,956 | No comparison | 30 | SEC filing |
| Dec 30, 2020 | Initial | $26,802,122 | No comparison | 44 | SEC filing |
| Oct 30, 2020 | Initial | $2,000,000 | No comparison | 3 | SEC filing |
| Aug 22, 2019 | Initial | $3,000,000 | No comparison | 25 | SEC filing |
| Sep 21, 2018 | Initial | $639,000 | No comparison | 14 | SEC filing |
| May 19, 2017 | Initial | $2,635,567 | No comparison | 19 | SEC filing |
| Aug 10, 2016 | Initial | $916,161 | No comparison | 11 | SEC filing |
| Jun 30, 2014 | Initial | $501,810 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-524116
Source: Form D, filed Sep 16, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Brinkerhoff | Director |
| Bill Burns | Director |
| Rafael Castilla | Director |
| Constance Chang | Executive |
| Loic Couraud | Director |
| Felicia David Visser | Director |
| David Esposito | Director, Executive |
| Aaron Fletcher | Director |
| John Freshley | Director, Executive |
| Christine Gibbons | Director |
| Mark Hooper | Director |
| Jeffrey A Jamison | Executive |
| Marian Nakada | Director |
| Stella Robertson | Director |
| Michal Silverberg | Director |
| David Zacks | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
524 S. Main St Suite 110
Ann Arbor, MI, 48104
Ann Arbor, MI, 48104